Stockscreener 앱 받기
8.11
6.71%
0.51
Abcellera Biologics Inc 주식(ABCL)의 최신 뉴스
Is AbCellera Biologics (ABCL) One of the Best Stocks with Biggest Upside? - Yahoo Finance
ABCL Stock Clocks Best Week Since February On Clinical Data Anticipation, Baker Bros Stake Boost - Stocktwits
ABCL News | ABCELLERA BIOLOGICS INC (NASDAQ:ABCL) - ChartMill
ABCL Jumps As Jazz Deal Fuels Antibody Pipeline Momentum - StocksToTrade
AbCellera Biologics Stock (ABCL) Opinions on Recent Technical Breakout and Pipeline Progress - Quiver Quantitative
Why Did SLS, MRNA, ABCL Stocks Surge To 52-Week Highs Last Week? - Stocktwits
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains? - MSN
Enterprise value to revenue forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
Enterprise value to EBIT forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
AbCellera Biologics(ABCL) Stock Options Chain | Quotes & News - Moomoo
Price to sales forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
Price to earnings forward of AbCellera Biologics Inc. – NASDAQ:ABCL - TradingView
JonesTrading Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $13 - Moomoo
Abcellera Biologics stock hits 52-week high at 6.79 USD By Investing.com - Investing.com Nigeria
ABCL Stock Pops As Jazz Deal Fuels Oncology Ambitions - StocksToTrade
Abcellera Biologics stock hits 52-week high at 6.79 USD - Investing.com UK
AbCellera Biologics, Inc. Actuals & Estimates (NASDAQ:ABCL) - TradingView
ABCL Forecast — Price Target — Prediction for 2027 - TradingView
Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal - Yahoo Finance
Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration - Insider Monkey
12 Best AI Drug Discovery Stocks Hedge Funds Are Loading Up On - Insider Monkey
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - MSN
Abcellera Biologics Inc (ABCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AbCellera Biologics (ABCL) 2026 Bloom Burton & Co. Healthcare Investor Conference summary - Quartr
Abcellera Biologics Inc (ABCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Abcellera Biologics Inc (ABCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Abcellera Biologics Inc (ABCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies - TradingView
BMO Capital Maintains AbCellera Biologics(ABCL.US) With Buy Rating, Maintains Target Price $7 - Moomoo
A potential billion-dollar deal looks for new ways to beat back cancer - The Business Journals
Abcellera Biologics Inc (ABCL) Institutional Confidence - TradingKey
Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies - BioSpace
ABCL and Jazz Pharmaceuticals Enter Collaboration for T-Cell Eng - GuruFocus
Is ABCELLERA BIOLG (ABCL) Outperforming Other Medical Stocks This Year? - MSN
AbCellera (ABCL) Partners with Jazz Pharmaceuticals for Cancer R - GuruFocus
AbCellera, Jazz Partner on Next-Generation Cancer Antibodies - TipRanks
AbCellera (NASDAQ: ABCL) inks Jazz cancer antibody pact with $56M upfront, big milestones - Stock Titan
Jazz taps Abcellera in potential $4B antibody discovery deal - BioWorld News
Jazz Pharmaceuticals, AbCellera announce oncology deal - grafa.com
Jazz, AbCellera in deal to develop T-cell engaging multispecific antibodies - MSN
Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmaceuticals and AbCellera Enter Collaboration - Pharmaceutical Executive
Jazz Pharmaceuticals, AbCellera partner on cancer antibodies By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals, AbCellera partner on cancer antibodies - Investing.com UK
Jazz Pharmaceuticals (JAZZ) Partners with AbCellera for $848M An - GuruFocus
Jazz Pharmaceuticals plc And AbCellera Biologics Inc Announces Collaboration To Discover Next-Generation T-Cell Engaging Multispecific Antibodies - marketscreener.com
Jazz Pharmaceuticals, AbCellera Biologics to Collaborate on T-cell Engaging Multispecific Antibodies - marketscreener.com
AbCellera: An AI-Era Antibody Platform Trading For Little More Than Its Cash (NASDAQ:ABCL) - Seeking Alpha
Abcellera Biologics Inc (ABCL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Abcellera Biologics Inc (ABCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Abcellera Biologics Inc (ABCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Abcellera Biologics Inc (ABCL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AbCellera Biologics Faces Stock Volatility Amid Strategic Decisions - timothysykes.com
3.86%
자본화:
|
볼륨(24시간):